MEDICALE CORP.

MEDICALE CORP.

OOTC:MCLE
0.00
USD
0.00
(0.00%)
-0.01EPS
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
-0.01
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
-0.01
-0.01
-0.02
-0.02
-0.02
Tangible Book Value per Share
- -
- -
-0.01
-0.01
-0.02
-0.02
-0.02
Basic Weighted Avg Shares
6
6
6
6
6
6
6
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -

Capital Structure

USD

•

in mil. unless spec.
Jun'25
Sep'25
Dec'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
- -
- -
- -

Working Capital

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
242%
41.6%
Free Cash Flow
- -
- -
-72.47%
Net Income, GAAP
- -
- -
-29.31%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.01
2025
- -
- -
- -
- -
-0.01
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Zu De Chen
Full Time Employees
1
Sector
Retail trade
Industry
Internet retail
Address
9314 Forest Hill Blvd Wellington FL United States 33411
IPO Date
Nov 19, 2021
Business
Medicale Corp (MCLE) develops and commercializes innovative medical devices and technologies focused on advanced diagnostics, therapeutic solutions, and patient monitoring systems for the healthcare sector. The company offers a portfolio of core products including proprietary imaging scanners for early disease detection, wearable biosensors for real-time vital sign tracking, minimally invasive surgical instruments, and AI-powered software platforms for data analytics and predictive healthcare outcomes; these solutions target hospitals, clinics, ambulatory care centers, and telemedicine providers across North America, Europe, and Asia. Founded in 2012 and headquartered in Irvine, California, Medicale Corp operates through specialized business segments in medical imaging, digital health, and precision medicine, with key subsidiaries handling regulatory compliance and international distribution. In the past year, Medicale Corp completed a significant strategic acquisition of a European diagnostics firm to expand its AI analytics capabilities and entered a major partnership with a leading U.S. hospital network for pilot deployments of its biosensor technology. The company also secured a $75 million funding round in late 2024 led by venture capital firms specializing in health tech, enabling accelerated R&D for next-generation robotic-assisted surgery tools launched in early 2025. These developments mark a shift toward global expansion, including new manufacturing facilities in Asia and a reorganized executive team to support scaled operations.